Skip to main content
. 2020 Jun 25;139:110059. doi: 10.1016/j.chaos.2020.110059

Table 1.

ML and AL technology in SARS-CoV-2 Screening.

Publication ML/AI method Types of data No of patients Validation method Sample size Accuracy
Ardakani, A. A et al., [28] Deep Convolutional Neural Network ResNet-101 Clinical, Mamographic 1020, 86 Holdout 1020 CT images of 108 volume of patients with laboratory confirmed Covid-19, 86 CT images of viral and atypical pneumonia patients, Accuracy: 99.51% Specificity: 99.02%
Ozturk, T. et al., [29] Convolutional Neural Network DarkCovidNet Architecture Clinical, Mamographic 127, 43 f, 82 m 500, 500 Cross-validation 127 X-ray images with 43 female and 82 male positive cases 500 no-findings and pneumonia cases of 500 Accuracy: 98.08% on Binary classes Accuracy: 87.02% on Multi-classes
Sun, L et al., [30] Support Vector Machine Clinical, laboratory features, Demographics 336, 220 Holdout 336 infected patients with PCR kit, 26 severe/critical cases and 310 non-serious cases and with another related disease79 hypertension, 29diabetes, 17 coronary disease and 7 having history of tuberculosis Accuracy: 77.5% Specificity: 78.4% AUROC reaches 0.99 training and 0.98 testing dataset
Wu, J. et al., [31] Random forest Algorithm Clinical, Demographics 253, 169, 49,24 Cross-validataion Total of 253 samples from 169 patients suspected with Covid-19 collected from multiple sources. Clinical blood test of 49 patients derived from commercial clinic center. 24 samples infected patient with Covid-19 Accuracy: 95.95% Specificity: 96.95%